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LABORATORY SCIENCE
Exertion of the suppressive effects of IFN-γ on
experimental immune mediated blepharoconjunctivitis in
Brown Norway rats during the induction phase but not
the effector phase
A Fukushima, K Fukata, A Ozaki, M Takata, N Kuroda, H Enzan, H Ueno
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Background/aims: Interferon gamma (IFN-γ) knockout mice exhibit severe allergic conjunctivitis (AC),
indicating that IFN-γ regulates the development of AC. The authors examined whether this inhibitory
effect of IFN-γ is exerted during the induction or effector phase of experimental AC.
Methods: Experimental immune mediated blepharoconjunctivitis (EC) was induced in Brown Norway (BN)
rats, using ovalbumin (OVA) as the antigen. To investigate the role of IFN-γ in the induction phase, EC was
induced by active immunisation and IFN-γ (10 µg/time, total 70 µg), or phosphate buffered saline (PBS) as
a control, was injected intraperitoneally every other day from the day of immunisation. The rats were chal-
lenged with OVA eye drops 13 days after immunisation, and 24 hours later, the eyes were harvested for
histology. To examine the effects of IFN-γ in the effector phase, OVA specific T cells were transferred into
syngeneic rats and IFN-γ (10 µg/time, total 50 µg) or PBS was injected each day after the transfer until
induction of EC 4 days later with an OVA challenge. To investigate the role of endogenous IFN-γ during
the effector phase, an anti-IFN-γ monoclonal antibody (3 mg/time) was injected on days 3 and 4.
Results: Injection of IFN-γ into actively immunised rats suppressed eosinophilic infiltration but not infiltra-
tion of mononuclear cells. In contrast, neither IFN-γ nor anti-IFN-γ affected EC in passively immunised rats.
Conclusion: IFN-γ is a suppressive cytokine for the development of EC and exerts this suppressive
effect during the induction phase.
Patients with severe cases of allergic conjunctivitis (AC)exhibit both eosinophilic and lymphocytic infiltrationinto the conjunctiva.1 2 To understand the mechanism
that leads to the development of severe AC, we established a
model of AC in Brown Norway (BN) rats termed experimental
immune mediated blepharoconjunctivitis (EC).3 4 A series of
experiments realised within the context of this model identi-
fied an important role for T helper 2 (Th2) immunity in the
development of EC.3–5 As clearly demonstrated in many other
experimental models, Th1 cells counteract Th2 cells,6 7 so that
the development of diseases can be inhibited by augmenting
Th1 immunity.8 9 Our previous report demonstrated that IL-12,
a Th1 differentiating cytokine, was able to suppress Th2 func-
tion in vitro.10 However, systemic injection of IL-12 during the
induction phase of EC augmented lymphocytic infiltration,10
suggesting that the Th1/Th2 balance in vivo is unlikely to be
modulated by the injection of a single cytokine.
Using cytokine knockout mice, it was demonstrated that
interferon gamma (IFN-γ) is an inhibitory cytokine for the
development of AC.11 Whether this inhibitory effect is exerted
during the induction phase or effector phase remains unclear,
because the assessment was performed using only active
immunisation systems. To understand the inhibitory mech-
anism of IFN-γ, we used both active and passive immunisation
systems12 to study the roles of IFN-γ in the induction and
effector phases, respectively. Here we demonstrate that this
inhibitory effect was exerted in the induction phase, but not in
the effector phase.
MATERIALS AND METHODS
Rats
Eight to 12 week old male BN rats (Clea Japan, Tokyo, Japan)
were maintained in a pathogen-free animal facility at Kochi
Medical School. All animal procedures conformed to the
ARVO resolution on use of animals in research.
Reagents
Recombinant rat IFN-γ was purchased from Peprotech EC Ltd,
UK. An anti-IFN-γ monoclonal antibody13 was purchased from
U-CyTech bv, Utrecht, Netherlands. Normal mouse IgG was
obtained from sera of Balb/c mice by precipitation at 40%
saturation with ammonium sulphate, then purified by protein
G-Sepharose 4B fast flow chromatography (Pharmacia LKB
Biotechnology, Uppsala, Sweden). Monoclonal antibodies
(Abs) used here for staining were specific for rat cells.
Anti-RT1B (OX-6) and anti-RT1D (OX-17) were labelled with
FITC (Pharmingen, San Diego, CA, USA). Anti-CD3 (G4.18,
Pharmingen), anti-CD4 (OX-38), anti-CD8 (OX-8), anti-CD25
(OX-39, Pharmingen), and anti-CD45RA (OX-33, Seortec,
Oxford, UK) were labelled with biotin. Anti-CD11b (X42,
Antigenix America, NY) was PE labelled. Streptavidin-PE was
purchased from Pharmingen.
Active immunisation and treatment protocol
BN rats received a subcutaneous injection in the left hind
footpad of 100 µl containing 100 µg of ovalbumin (OVA; grade
V, Sigma Immunochemicals, St Louis, MO, USA) emulsified
with CFA (Yatron, Tokyo, Japan). The day of immunisation
was designated day 0. The rats were then assigned to either an
IFN-γ treated or a phosphate buffered saline (PBS) treated
group. IFN-γ (0.1, 1, or 10 µg per injection) and PBS
treatments were given by intraperitoneal injection from day 0
to day 13, every other day. On day 13, all rats were challenged
with OVA eye drops (250 µg in 50 µl of PBS). Twenty four
hours after challenge, they were killed and their eyes, blood,
and lymph nodes were harvested for histological studies,
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measurement of antibody production, and proliferative
responses or flow cytometric analysis.
Passive immunisation by adoptive transfer of OVA
specific T cells and treatment protocol
The establishment of OVA specific T cell lines has been
described in detail elsewhere.14 In brief, OVA primed lymph
node cells (2.5 × 106/ml) were cultured in a 75 cm2 culture flask
(Becton Dickinson Labware, Franklin Lakes, NJ, USA) at a
volume of 20 ml RPMI 1640 medium (Sigma Aldrich Co, St
Louis, MO, USA) supplemented with 10% FCS (ICN Biomedi-
cal, Japan Co, Tokyo, Japan), 2-ME (5 × 10−5 M), L-glutamine (2
mM), penicillin (100 U/ml), and streptomycin (100 µg/ml) in
the presence of OVA (50 µg/ml). Three days later, stimulated
cells were expanded for 4 days in the above medium
supplemented with 100 IU/ml of recombinant human IL-2
(rhIL-2, Takeda, Osaka, Japan) in the absence of OVA. After
the expansion period, the cells (15 × 106 cells/flask) were res-
timulated with OVA (50 µg/ml) in the presence of irradiated
(30 Gy) syngeneic thymocytes (300 × 106 cells/flask) as
antigen presenting cells (APC) in 10% FCS-RPMI 1640
medium at a volume of 50 ml. Three days later, live
lymphocytes were separated by gradient centrifugation (Lym-
phocyte Separation Medium, Organon Teknika Corporation,
West Chester, PA, USA) and expanded with rhIL-2 as above.
Then, these cells were stimulated with OVA in the presence of
irradiated thymocytes. At the same time, antigen specificity
was assessed by proliferation assay. Three days after the third
stimulation, live cells were collected by gradient centrifuga-
tion. Phenotypes of these cells were examined by flow
cytometoric analysis. Fifteen million of these T cells were
injected intravenously into syngeneic male BN rats (recipi-
ents). The day of cell transfer was designated day 0. The rats
were assigned to either an IFN-γ treated or a PBS treated
group. IFN-γ (10 µg per injection) and PBS treatments were
given daily by intraperitoneal injection from day 0 to day 4. For
the anti-IFN-γ treatment, either anti-IFN-γ or normal mouse
IgG (3 mg per injection) was injected intraperitoneally on day
3 (24 hours before challenge) and day 4 (at the time of chal-
lenge). EC was induced on day 4 and was evaluated in a man-
ner similar to that used for active immunisation.
Counts of infiltrating cells in the conjunctiva
The eyes, including the lids, were fixed in 10% buffered
formalin and embedded in paraffin. Central vertical plane sec-
tions of 4 µm thickness were stained with haematoxylin-eosin
and May-Giemsa. Two masked observers counted the num-
bers of infiltrating mononuclear cells, eosinophils, and
neutrophils in the conjunctiva stained by these different
methods. Counting of mononuclear cells was performed using
an eyepiece grid of 400× magnification.3–5 10 12 14 Because cellu-
lar infiltration was not always uniform throughout the
sections, three different portions (conjunctival fornix and two
portions of palpebral conjunctivas) were selected for counting
and an average was calculated. Eosinophils were counted
throughout the section.
Flow cytometric analysis
OVA primed lymph node cells and OVA specific T cells were
incubated for 30 minutes on ice with Abs at optimal concen-
trations (0.02–0.5 µg/5 × 105 cells). After the incubation, cells
were washed with cold 2% FCS-PBS. These cells were analysed
on a FACScan (Becton Dickinson, Mountain View, CA, USA)
and acquisition and analysis were performed using CellQuest
software.
Assessment of cellular immune responses
Lymphocyte proliferation assays were done in quadruplicate
in 96 well flat bottom plates. Lymph node cells (3 ×105
cells/well) from individual rats were cultured in a final volume
of 0.2 ml RPMI 1640 medium supplemented with 2-ME and
5% FCS. Cells were stimulated with OVA at final concentra-
tions of 0.1, 1, 10, and 100 µg/ml. After incubation for 72 hours
at 37°C in a humidified atmosphere with 5% CO2, cultures
were pulsed for 16 hours with 0.5 µCi/well of [3H] thymidine
(Japan Atomic Energy Research Institute, Tokai, Japan). In
the case of OVA specific cell lines, line cells (3 × 104/well) were
stimulated with OVA in the presence of 30 Gy irradiated thy-
mocytes (6 × 105/well) in the same condition as above. Forty
eight hours later, [3H] thymidine was pulsed for 16 hours. Cul-
tures were then harvested and the radioactivity was measured
by standard techniques. Data were expressed as stimulation
indices (mean count per minute (cpm) in stimulated cultures/
mean cpm in unstimulated cultures).
RT-PCR analysis of cytokines
RNA from OVA specific T cells prepared as above was isolated
by acid/guanidine isothiocyanate/phenol/chloroform extrac-
tion and transcribed into cDNA using AMV reverse tran-
scriptase XL (Takara Biomedicals, Tokyo, Japan) in a 100 µl
reaction mixture containing 5 µg of total RNA. A cDNA equiv-
alent to 0.25 µg of total RNA was amplified in a 20 µl reaction
mixture containing 250 µMof dNTP, 0.2 µMof the primer pair,
2 µl of a 10-fold dilution of PCR buffer, and 2.5 U of Taq DNA
polymerase (Perkin-Elmer/Cetus, Emerywille, CA, USA). PCR
was performed on a DNA thermal cycler (Perkin Elmer, Foster
City, CA, USA) for a cycle of 94°C for 10 minutes, 35 (β-actin,
IL-10 and IFN-γ) or 40 (IL-2 and IL-4) cycles 94°C for 30 sec-
onds, 55°C (β-actin, IL-2, IL-10 and IFN-γ) or 60°C (IL-4) for
30 seconds, and 72°C for 90 seconds. The molecular size
marker used was X174/Hae III digest (Wako, Osaka, Japan).
PCR products were electrophoresed in a 2% agarose gel with
ethidium bromide staining. The predicted sizes of PCR-
product and primer pairs13 were as follows: β-actin: product
size = 759 bp, 5′TTGTAACCAACTGGGACGATATGG3′ and
5′GATCTTGATCTTCATGGTGCTAGG3′; IL-2: product size =
342 bp, 5′CAAAGGAAACACAGCAGCACCTGG3′ and 5′TCCT-
CAGAAATTCCACCACAGTTG3′, IL-10: product size = 512 bp,
5′TCAGCACTGCTATGTTGCCTGCTC3′ and 5′ GAGTGTCACG-
TAGGCTTCTATGC3′, IFN-γ: product size = 288 bp, 5′ATCT-
GGAGGAACTGGCAAAAGGACG3′ and 5′CCTTAGGCTAGAT-
TCTGGTGACAGC3′. IL-4 primer pair (GenBank Accession No
X16058) was purchased from BioSource International, Ca-
marillo, CA, USA and the predicted size was 177 bp.
Detection of IgE in serum by ELISA
Total IgE in serum was measured using an ELISA kit
(Morinaga, Yokohama, Japan) following the manufacturer’s
recommendations.
Statistical analysis
Statistical comparisons of the number of infiltrating cells and
the percentage of a cell surface molecule positive cells were
performed with the Mann-Whitney U test.
RESULTS AND DISCUSSION
A previous report using knockout mice demonstrated that
IFN-γ is an inhibitory molecule for the development of experi-
mental AC.11 However, it is still unclear whether IFN-γ exerts
this inhibitory effect during the induction or effector phase.
Therefore, we examined the role of IFN-γ in the development
of EC using both active and passive immunisation systems,12
which are useful for investigating the induction and effector
phases, respectively.
To investigate the systemic effects of IFN-γ on the induction
phase in the development of EC, we induced EC in BN rats by
active immunisation. Injection of IFN-γ (10 µg per injection)
inhibited infiltration of eosinophils in rats with EC induced by
active immunisation (p = 0.0265), whereas other inflamma-
tory cells were not affected by this treatment (Fig 1). Lower
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doses of IFN-γ (0.1 µg and 1 µg per injection) did not affect EC
(data not shown). Thus, excess amounts of IFN-γ inhibited the
development of EC during the induction phase. These data
agree with the previous result that cellular infiltration into the
conjunctiva was much more extensive in IFN-γ knockout
mice11 than in wild type mice.
To study the role of IFN-γ on the development of EC during
the effector phase, we established OVA specific T cell lines.
These cell lines were CD3+, CD4+, CD8−, and CD45RA− (Fig 2A).
These cells vigorously proliferated against OVA (Fig 2B). They
expressed IL-4, IL-10, and IFN-γ but not IL-2, indicating that
they were mixture of Th1 and Th2 cells (Fig 2C). We induced
EC in BN rats by transfer of these T cells and then injected
IFN-γ intraperitoneally. Because lower doses of IFN-γ (0.1 and
1 µg per injection) were ineffective for the inhibition of EC
induced by active immunisation, effects of IFN-γ were tested
only at 10 µg per injection. No difference was observed
between the IFN-γ injected group and the control group (Fig
3A) at the same dose of IFN-γ that suppressed eosinophilic
infiltration in actively immunised BN rats (Fig 1). Next, to
investigate the involvement of endogenous IFN-γ in the effec-
tor phase of EC, we injected an anti-IFN-γ antibody into rats
developing EC. No differences in cellular infiltration into the
conjunctiva were noted between the anti-IFN-γ treated group
and the normal mouse IgG treated group (Fig 3B). The
ineffectiveness of IFN-γ during the effector phase was further
demonstrated by the finding that topical administration of
IFN-γ just before antigen challenge did not affect EC (data not
shown). These data suggest that IFN-γ is not likely to be
involved in the effector phase of EC in BN rats. Together with
the data that high doses of IFN-γ inhibit eosinophilic infiltra-
tion in BN rats induced by active immunisation (Fig 1),we can
conclude that IFN-γ is an inhibitory cytokine for the develop-
ment of EC and that it exerts suppressive effects only during
the induction phase.
Figure 1 Effects of IFN-γ on EC induced by active immunisation. BN rats were actively immunised with OVA and 13 days later they were
challenged with OVA. IFN-γ (10 µg per injection) or PBS was injected intraperitoneally every other day from the day of immunisation until
challenge. Twenty four hours after challenge, the eyes were harvested for histology. Mononuclear cells were counted per field, whereas
eosinophils were counted throughout the section. Eosinophilic infiltration was attenuated by IFN-γ treatment, while infiltration of mononuclear
cells was not affected. (A, B) PBS treated group. (C, D) IFN-γ treated group. (A, C) ×80, (B, D) ×320. One representative of each group is
shown. (E) Number of infiltrating mononuclear cells per field and number of infiltrating eosinophils throughout the section. An average of the
data from six rats is shown for each group. *p<0.05. Error bar indicates standard deviation.
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To ascertain the cellular effects of IFN-γ treatment, we
examined phenotypic compartments in draining lymph node
cells especially focusing on expression of MHC class II,
because IFN-γ promotes MHC class II expression. Compared
with the control group, no difference was noted on T cell
compartment including CD25 expression (Fig 4A). On the
contrary, expression of MHC class II, particularly RT1D, was
augmented in the IFN-γ treated group (Fig 4A). In parallel,
CD45RA, which is a B cell marker, expressing cells were
increased. Thus, it could be considered that treatment proto-
col here activated B cell compartment, leading to an increased
number of MHC class II positive cells. Next, we tested antigen
specific cellular and humoral immunity in rats that received
active immunisation. IFN-γ treatment did not appear to affect
antigen specific proliferation of lymph node cells (Fig 4B) or
the total IgE level in serum (Fig 4C). Additionally, antigen
specific IgE production in serum was similar between the two
groups (data not shown). Because IgE was not suppressed by
IFN-γ treatment, IFN-γ treatment did not profoundly affect
Th2 immunity. Recently, it was demonstrated that sensitivity
to IFN-γ is different even among Th2 subpopulations,15 in that
IFN-γ affects IL-5 expression rather than IL-4 expression.
These data are in good agreement with our findings that IL-4
dependent IgE production was not affected but IL-5 depend-
ent eosinophilic infiltration was attenuated by IFN-γ treat-
ment. It may also be that endogenous IFN-γ is relatively
abundant and inhibits Th2 immune responses, so that the
effects of additional IFN-γ are not remarkable. Although it is
well known that fully differentiated Th2 cells are more
sensitive to IFN-γ than Th1 cells,16 treatment with IFN-γ dur-
ing the induction phase might have affected the development
of Th1 and Th2 cells equally, thus not affecting the Th1/Th2
balance.
Figure 2 Characterisation of OVA specific T cell lines. OVA specific T cell lines were established by repeated stimulation with OVA in the
presence of irradiated thymocytes as APC. (A) Expression of cell surface molecules. After a third stimulation with OVA, cells were analysed by
FACscan. This cell line was identified to be CD4 positive T cells. One of three representative experiments was shown. (B) Antigen specific
proliferation. After a second stimulation with OVA, cells were rested with rhIL-2 for 4 days. Then, proliferative capability of these cells against
OVA was examined in the presence of APC. These T cells proliferated against OVA vigorously. Results were the average of three independent
cell lines. Background cpm was 1767 (SD 449). (C) Expression of cytokine mRNA. After a third stimulation with OVA, mRNA was extracted
from these T cells for RT-PCR. IL-4, IL-10, and IFN-γ were detected, whereas IL-2 was not detectable. MM = molecular marker.
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Considering the effects of IFN-γ on immune responses, it is
necessary to pay attention to the involvement of innate
immunity17 as well as acquired immunity discussed as above.
Involvement of innate immunity could be less in EC by passive
immunisation than that by active immunisation, because pas-
sive EC is putatively mediated by antigen specific T cells. This
differential involvement of innate immunity on the develop-
ment of EC between by active and passive immunisation
might be related to the fact that suppressive effects of IFN-γ
were noted in active EC but not passive EC. Although we have
not investigated the interaction of IFN-γ linking the innate
immune system and acquired immune system,18 this interac-
tion, at least in part, should take a role in the suppressive
effects of IFN-γ on EC. One important cell compartment for
this linkage is dendritic cells (DC).19 Because IFN-γ was shown
to activate DC function to promote IL-12 production,20
increased Th1 level might have suppressed Th2 level, thus
leading to less eosinophilic infiltration.
In conclusion, IFN-γ exerts its suppressive effects on EC
during the induction phase, but not the effector phase.
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Figure 3 Effects of IFN-γ and an anti-IFN-γ monoclonal antibody on
EC induced by transfer of OVA specific T cells. OVA specific T cells
were transferred into syngeneic BN rats. Four days later, the rats
were challenged with OVA. IFN-γ (10 µg per injection) or PBS was
intraperitoneally injected daily from the day of immunisation to the
day of challenge (A). An anti-IFN-γ monoclonal antibody or normal
mouse IgG (3 mg per injection) was injected on day 3 and day 4
(B). Twenty four hours after challenge, the eyes were harvested for
histology. The number of infiltrating mononuclear cells and
eosinophils in rats treated with either IFN-γ (A) or anti-IFN-γ (B) are
shown. Neither IFN-γ nor anti-IFN-γ treatment affected the
progression of EC induced by transfer of OVA specific T cells.
Averages of data from six rats (A) and four rats (B) are shown for
each group. Error bar indicates standard deviation.
Figure 4 Effects of IFN-γ on immune responses. Lymph node cells
and sera were collected from actively immunised rats treated with
IFN-γ or PBS, as detailed in the Materials and methods. (A)
Expression of cell surface molecules in lymph node cells evaluated by
flow cytometric analysis. Data were presented as an average of
percentages of positive cells expressing a particular molecule. IFN-γ
treatment increased B cell compartment and RT1D positive cells,
compared to PBS treatment. Averages of six individual rats per
groups are shown. *p<0.05. Error bar indicates standard deviation.
(B) Antigen specific proliferation of lymph node cells against OVA.
No apparent differences were noted between the two groups. Data
from six individual rats were combined in each group. (C) Total IgE
in serum. A similar amount of IgE was detected in both groups. Data
from six individual rats were combined in each group.
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